APA (7th ed.) Citation

Ang Jia, Hongfei Jiang, Wenjing Liu, Pengwei Chen, Qi Xu, Renshuai Zhang, & Jufeng Sun. (2023). Novel application potential of cinaciguat in the treatment of mixed hyperlipidemia through targeting PTL/NPC1L1 and alleviating intestinal microbiota dysbiosis and metabolic disorders. Elsevier.

Chicago Style (17th ed.) Citation

Ang Jia, Hongfei Jiang, Wenjing Liu, Pengwei Chen, Qi Xu, Renshuai Zhang, and Jufeng Sun. Novel Application Potential of Cinaciguat in the Treatment of Mixed Hyperlipidemia Through Targeting PTL/NPC1L1 and Alleviating Intestinal Microbiota Dysbiosis and Metabolic Disorders. Elsevier, 2023.

MLA (9th ed.) Citation

Ang Jia, et al. Novel Application Potential of Cinaciguat in the Treatment of Mixed Hyperlipidemia Through Targeting PTL/NPC1L1 and Alleviating Intestinal Microbiota Dysbiosis and Metabolic Disorders. Elsevier, 2023.